Ropivacaine – SLS 2 mg/ml

 

1.Therapeutic indications:

Ropivacaine SLS 2 mg/ml is indicated for acute pain management in:
– Adults and adolescents over 12 years of age (postoperative pain management)
– Infants from 1 year and children aged 12 years or less (pre- and postoperative pain management)
– In neonates, infants and children aged 12 years or less (pre- and postoperative pain management)

2. Dosage:

Adults and adolescents over 12 years of age:
Method of administration: perineural and epidural administration by infusion

  Conc.

mg/ml

Volume

ml

Dose

mg

ACUTE PAIN MANAGEMNT
Lumbar Epidural Administration
Continuous infusion labor pain 2.0 6 – 10 ml/h 12 – 20 mg/h
Postoperative pain management 2.0 6 – 14 ml/h 12 – 28 mg/h
Thoracic Epidural Administration
Continuous infusion (postoperative pain management) 2.0 6 – 14 ml/h 12 – 28 mg/h

 ِApproved:

Categories